Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fortuna Papa"'
Autor:
Biagio Pinchera, Lorenzo Spirito, Antonio Riccardo Buonomo, Maria Foggia, Rosa Carrano, Fabrizio Salemi, Elisa Schettino, Fortuna Papa, Roberto La Rocca, Felice Crocetto, Luigi Napolitano, Riccardo Villari, Ivan Gentile
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionIn solid organ transplant recipients, COVID-19 is associated with a poor prognosis because of immunosuppression. Some studies suggest a potential therapeutic role of mammalian Target of Rapamycin (mTOR) inhibitors in SARS-CoV-2 infection.
Externí odkaz:
https://doaj.org/article/7c6dd49e2a06468889645378f2abdb23
Autor:
Maria Cristina De Martino, Richard A Feelders, Claudia Pivonello, Chiara Simeoli, Fortuna Papa, Annamaria Colao, Rosario Pivonello, Leo J Hofland
Publikováno v:
Endocrine Connections, Vol 8, Iss 9, Pp R144-R156 (2019)
Adrenocortical carcinomas (ACCs) are rare tumors with scant treatment options for which new treatments are required. The mTOR pathway mediates the intracellular signals of several growth factors, including the insulin-like growth factors (IGFs), and
Externí odkaz:
https://doaj.org/article/8ed992fa4ecd43519ef97c5d2d291c7d
Autor:
Ashley B. Grossman, Tiziana Feola, Daniele Gianfrilli, Fortuna Papa, Giulia Puliani, Andrea M. Isidori, Marco Crocco, Emilia Sbardella
Survival rates among childhood cancer survivors (CCSs) have significantly risen in the last 40 years due to substantial improvements in treatment protocols. However, this improvement has brought with it serious late effects that frequently involve th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7734ca2b0cfecb31e7f44804c0562f3f
http://hdl.handle.net/11573/1408663
http://hdl.handle.net/11573/1408663
Autor:
Roberta Patalano, D. Angellotti, Davide Iacuaniello, Rosario Ferrigno, Chiara Simeoli, Mariarosaria Negri, A. Colao, M. C. De Martino, Rosario Pivonello, Claudia Pivonello, Fortuna Papa
Publikováno v:
Journal of Endocrinological Investigation
Purposes Pasireotide is the first medical therapy officially approved for adult patients with Cushing’s disease (CD) experiencing failure of pituitary surgery or not candidates for surgery. The current study aimed at investigating pasireotide effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54fac622e244b05df519a1a1676a617a
http://hdl.handle.net/11588/765716
http://hdl.handle.net/11588/765716
Autor:
Roberta Patalano, De Martino Maria Cristina, Claudia Pivonello, Rosario Pivonello, Chiara Simeoli, Fortuna Papa, Mariarosaria Negri, Gennaro Gilda Di, Angelis Cristina de, Tatiana Montò
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e46838dcaea285f115a76c7b411fb65
https://doi.org/10.1530/endoabs.63.p1020
https://doi.org/10.1530/endoabs.63.p1020
Autor:
Claudia Pivonello, Renata S. Auriemma, Cristina de Angelis, Rosario Ferrigno, Maria Cristina De Martino, Gilda Di Gennaro, Annamaria Colao, Fortuna Papa, Rosario Pivonello, Roberta Patalano, Mariarosaria Negri, Donatella Paola Provvisiero, Chiara Simeoli
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
Scientific Reports
Scientific Reports
Primary or acquired resistant mechanisms prevent the employment of individualized therapy with target drugs like the mTOR inhibitor everolimus (EVE) in hepatocellular carcinoma (HCC). The current study evaluated the effect of 1,25(OH)2Vitamin D (VitD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f3a5b206b7df8d518ef9ea9b2bba6a
http://hdl.handle.net/11588/765487
http://hdl.handle.net/11588/765487
Autor:
Leo J. Hofland, Chiara Simeoli, Annamaria Colao, Claudia Pivonello, Maria Cristina De Martino, Richard A Feelders, Rosario Pivonello, Fortuna Papa
Publikováno v:
Endocrine Connections, 8(9), R144-R156. Bioscientifica Ltd
Endocrine Connections
Endocrine Connections, Vol 8, Iss 9, Pp R144-R156 (2019)
Endocrine Connections
Endocrine Connections, Vol 8, Iss 9, Pp R144-R156 (2019)
Adrenocortical carcinomas (ACCs) are rare tumors with scant treatment options for which new treatments are required. The mTOR pathway mediates the intracellular signals of several growth factors, including the insulin-like growth factors (IGFs), and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff85a8167d5de2024915750a3f31b70c
https://pure.eur.nl/en/publications/06e7b2bc-588e-4caf-90e9-41fb1cc9e294
https://pure.eur.nl/en/publications/06e7b2bc-588e-4caf-90e9-41fb1cc9e294